In its first Scientific Meeting, the recently established Nanomedicines Innovation Network (NMIN) gathered its pan-Canadian teams of experts and other stakeholders to advance:

• NMIN’s plans to support innovative new research and commercialization strategies for nanomedicines development and uptake within the healthcare system;
• NMIN’s efforts to build capacity in the next generation of nanomedicine researchers and entrepreneurs to strengthen Canada’s position as a global leader in nanomedicines innovation; and
• networking and collaboration among researchers, clinicians, trainees, industry and government.